External validation of deep learning-derived 18F-FDG PET/CT delta biomarkers for loco-regional control in head and neck cancer.
Source check: Source checked. Not independent scientific confirmation.
Finding / tested result: External PET/CT validation links learned delta biomarkers to regional control in a separate cancer cohort; interpretation remains retrospective and noncausal.
Technology: Deep-learning PET/CT segmentation produces delta biomarkers evaluated against regional control in an external head-and-neck cancer cohort.
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- Deep-learning PET/CT segmentation produces delta biomarkers evaluated against regional control in an external head-and-neck cancer cohort.
- Limitation / still unknown
- Results are limited to the reported models, cohorts, datasets or experiments; broader generalization and clinical or operational benefit were not established.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://doi.org/10.2340/1651-226x.2025.43977
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.